These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Schwartz JD; Beutler AS Anticancer Drugs; 2004 Jun; 15(5):439-52. PubMed ID: 15166617 [TBL] [Abstract][Full Text] [Related]
5. Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial. Lai EC; Choi TK; Tong SW; Ong GB; Wong J World J Surg; 1986 Jun; 10(3):501-9. PubMed ID: 2425500 [No Abstract] [Full Text] [Related]
6. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y; Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810 [TBL] [Abstract][Full Text] [Related]
7. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma. Reidy DL; Schwartz JD Anticancer Drugs; 2004 Jun; 15(5):427-37. PubMed ID: 15166616 [TBL] [Abstract][Full Text] [Related]
8. [Clinical studies of intermittent hepatic arterial occlusion with infusion chemotherapy for unresectable hepatocellular carcinoma associated with arterioportal or arteriovenous shunts]. Yano S; Tarumi T; Yamamoto T; Tamura K; Nakase A Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):99-108. PubMed ID: 2544651 [TBL] [Abstract][Full Text] [Related]
9. Studies on the chemotherapy with 5-fluorouracil in transcatheter arterial chemoembolization (TAE) treated patients with resectable or non-resectable hepatocellular carcinoma. Osaka Study Group on Hepatocellular Carcinoma. Cancer Chemother Pharmacol; 1989; 23 Suppl():S29-32. PubMed ID: 2538262 [TBL] [Abstract][Full Text] [Related]
10. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study. He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175 [TBL] [Abstract][Full Text] [Related]
11. [Hepatic arterial chemotherapy combined with hyperthermia or arterial embolization in unresectable liver tumor]. Hamazoe R; Koga S; Maeda M; Shimizu N; Shimizu T; Sawata T; Ishiguro M; Inoue Y; Wakatsuki T; Murakami A Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2590-5. PubMed ID: 2843128 [TBL] [Abstract][Full Text] [Related]
12. [The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge]. Yamada R; Tsuda M; Sato M; Nakayama T; Nishioka S; Yataka I; Nakamura K; Onoyama Y; Kanno T; Nakatsuka H Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2621-6. PubMed ID: 2843130 [TBL] [Abstract][Full Text] [Related]
13. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial. Tian G; Liu J; Zhou JS; Chen W Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of prognostic factors in patients with hepatocellular cancer treated by hepatic arterial infusion chemotherapy]. Izumi R; Shimizu K; Yabushita K; Watanabe T; Horichi H; Kitabayashi K; Tani T; Urade M; Iyobe T; Segawa M Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2965-8. PubMed ID: 2551236 [TBL] [Abstract][Full Text] [Related]
15. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. Zhu LZ; Xu S; Qian HL World J Gastroenterol; 2018 Jun; 24(23):2501-2507. PubMed ID: 29930471 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma]. Shi Z; Guo Y; Liu D Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839 [TBL] [Abstract][Full Text] [Related]
18. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Hunt TM; Flowerdew AD; Birch SJ; Williams JD; Mullee MA; Taylor I Br J Surg; 1990 Jul; 77(7):779-82. PubMed ID: 2200559 [TBL] [Abstract][Full Text] [Related]
19. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Lau WY; Ho SK; Yu SC; Lai EC; Liew CT; Leung TW Ann Surg; 2004 Aug; 240(2):299-305. PubMed ID: 15273555 [TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Audisio RA; Doci R; Mazzaferro V; Bellegotti L; Tommasini M; Montalto F; Marchianò A; Piva A; DeFazio C; Damascelli B Cancer; 1990 Jul; 66(2):228-36. PubMed ID: 2164435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]